
Liver and Pancreatic Diseases in Pregnancy — Pattern, Diagnosis & Management
Abnormal liver tests occur in about 3–5% of pregnancies; the cause is either unique to pregnancy (ICP, HELLP, acute fatty liver) or unrelated (viral hepatitis, gallstones, chronic liver disease)
The trimester points to the diagnosis: hyperemesis in the first, intrahepatic cholestasis from the late second, and pre-eclampsia, HELLP, and acute fatty liver in the third
Pregnancy-specific liver diseases can progress quickly to liver failure, bleeding, and fetal death; timely delivery is often the treatment
Acute pancreatitis is rare (about 1 in 1,000–4,000) and is usually gallstone-related; early supportive care gives good outcomes
| Test | In normal pregnancy | Comment |
|---|---|---|
| Alkaline phosphatase (ALP) | Rises 2–4 times (placental isoenzyme) | Not useful alone in pregnancy |
| ALT, AST, GGT, bilirubin | Normal or slightly low | Any rise above the upper limit is abnormal; ALT above 40 IU/L needs a cause |
| Albumin | Falls by 20–30% (haemodilution) | Low albumin does not mean liver failure |
| Bile acids | Fasting level under 10 µmol/L | Raised in ICP; non-fasting levels are acceptable |
| Fibrinogen, clotting factors | Rise; prothrombin time unchanged | Prolonged PT or low fibrinogen points to AFLP, DIC, or liver failure |
| Skin signs | Spider naevi and palmar erythema are common | Not signs of chronic liver disease unless persistent after delivery |
| Feature | Intrahepatic cholestasis (ICP) | HELLP syndrome | Acute fatty liver (AFLP) | Hyperemesis |
|---|---|---|---|---|
| Timing | Late 2nd–3rd trimester (from about 28 weeks) | Late 2nd–3rd trimester (20 weeks to after birth) | Third trimester (30–38 weeks) | First trimester, settles by 20 weeks |
| Main features | Itching of palms and soles, worse at night; no rash | Pain in epigastrium or right upper quadrant, hypertension, headache | Nausea, vomiting, abdominal pain, jaundice, thirst, confusion | Severe vomiting, weight loss, ketosis |
| Liver tests | Raised bile acids (≥ 10 µmol/L); ALT often 2–10 times normal | AST and ALT raised, LDH high, haemolysis, platelets under 100 × 10⁹/L | ALT 3–10 times normal, bilirubin high, low glucose, high urate, ammonia, creatinine, long INR | Mild ALT rise in up to 50% |
| Treatment | Ursodeoxycholic acid (UDCA) 10–15 mg/kg/day in divided doses for itch; vitamin K if INR prolonged | Magnesium sulfate, BP control, steroids for lung maturity; deliver | Resuscitate, give glucose, plasma, and treat coagulopathy; deliver promptly | Fluids, antiemetics, thiamine |
| Risk | Stillbirth, preterm birth, meconium | Hepatic haematoma, rupture, DIC, AKI | Liver failure, DIC, death (maternal mortality about 10–20% without care) | Wernicke encephalopathy (rare) |
| After delivery | Itch and tests normalise in 2–6 weeks; recurrence 60–90% | Resolves in days; watch for AKI | Recovery in days to weeks; test for LCHAD deficiency in baby and mother | Resolves |
| Bile acid level | Risk | Delivery (RCOG, Royal College of Obstetricians and Gynaecologists) |
|---|---|---|
| Under 19 µmol/L | Low | Usually at term (about 40 weeks); earlier if severe itch |
| 19–39 µmol/L | Moderate | 38–39 weeks is reasonable |
| 40–99 µmol/L | Higher | Consider induction at 36–38 weeks |
| 100 µmol/L or more | Highest (stillbirth risk about 3% after 35 weeks) | Deliver at 35–36 weeks after steroids and counselling |
Monitoring: weekly liver tests and bile acids; fetal movement counts; cardiotocography is not reliable for predicting stillbirth in ICP
Differential for pruritus: skin disease, scabies, hepatitis (A, B, C, E), gallstones, pre-eclampsia, and autoimmune liver disease
| Topic | HELLP syndrome | Acute fatty liver of pregnancy |
|---|---|---|
| Diagnosis | Hypertension and proteinuria usually present; LDH ≥ 600 IU/L, AST ≥ 70, platelets under 100 × 10⁹/L (Tennessee criteria) | Swansea criteria (6 or more): vomiting, pain, polydipsia, encephalopathy, bilirubin above 0.8 mg/dL, glucose under 72 mg/dL, urate above 5.7 mg/dL, white cells above 11, bright liver or ascites on ultrasound, ALT above 42, ammonia above 47 µmol/L, creatinine above 1.7 mg/dL, PT above 14 s, steatosis on biopsy |
| First steps | Magnesium sulfate; BP control (labetalol, nifedipine); blood, platelet, and plasma ready; dexamethasone 10 mg IV to mature lungs | Glucose infusion; fresh frozen plasma, cryoprecipitate, platelets; treat hypoglycaemia and acidosis; HDU or ICU |
| Delivery | At 34 weeks or more, or if unstable: deliver after stabilisation; before 34 weeks: steroids for 24–48 hours if mother and fetus are stable | Prompt delivery after stabilisation; caesarean often needed with coagulopathy |
| Complications | Subcapsular haematoma, hepatic rupture, DIC, pulmonary oedema, AKI | Hepatic encephalopathy, AKI, pancreatitis, sepsis |
| Postpartum | Watch BP and platelets; HELLP can start after delivery | Maternal recovery in 1–2 weeks; screen child for long-chain fatty acid oxidation disorders |
| Virus | Key points | Management |
|---|---|---|
| Hepatitis A | Faeco-oral; usually mild; vertical transmission is rare | Supportive care; vaccinate contacts and newborn if mother has jaundice at delivery; hygiene |
| Hepatitis B | Screen every woman (HBsAg); vertical transmission 70–90% if HBeAg positive; chronic carriage in over 90% of infected babies | Check HBV DNA and ALT; tenofovir 300 mg daily from 28–32 weeks if DNA ≥ 200,000 IU/mL (or HBeAg-positive where DNA is unavailable); vaccine within 12–24 hours and HBIG (0.5 mL) for the newborn |
| Hepatitis C | Screen high-risk women; vertical transmission about 5% (higher with HIV) | No direct-acting antivirals in pregnancy; treat after delivery; test the baby at 18 months (or by RNA at 2–6 months); breastfeeding allowed |
| Hepatitis E | Common in India (genotype 1, waterborne); fulminant failure in 20–25%; mortality up to 20–30% in the third trimester | Supportive care, glucose, vitamin K, plasma; early ICU care; safe water and sanitation; no specific antiviral |
| Herpes simplex hepatitis | Fever, very high ALT, little jaundice; often fatal if missed | Start IV aciclovir early while awaiting PCR |
The National Viral Hepatitis Control Programme (NVHCP) promotes HBsAg screening of every pregnant woman, but reported routine antenatal screening is only about 65%
Newborns of HBsAg-positive mothers need the birth-dose hepatitis B vaccine and hepatitis B immunoglobulin (HBIG) within 24 hours; birth-dose coverage is reported at over 92%
Complete the full vaccine course and test the baby for HBsAg and anti-HBs at 9–12 months
Referral: women with high viral load or raised ALT go to a hepatology or gastroenterology service; free treatment is available through the programme
| Condition | Pregnancy advice |
|---|---|
| Cirrhosis and portal hypertension | Fertility is reduced; risk of variceal bleeding (about 20–30%), liver failure, and preterm birth; screen for varices by endoscopy in the second trimester; non-selective beta-blocker or variceal banding; assisted second stage to limit pushing |
| Autoimmune hepatitis | Continue prednisolone and azathioprine; flares can occur after delivery; fetal outcomes good if disease is quiet |
| Primary biliary cholangitis | Continue ursodeoxycholic acid; watch for itch and portal hypertension |
| Wilson disease | Continue treatment (zinc; reduce penicillamine or trientine dose by 25–50%); stopping causes liver failure |
| Budd–Chiari syndrome | Anticoagulation with low-molecular-weight heparin; specialist care |
| Liver transplant recipients | Wait 1 year after transplant with stable graft; tacrolimus, azathioprine, prednisolone are acceptable; stop mycophenolate before conception |
| Non-alcoholic fatty liver disease | Common with obesity and diabetes; raises gestational diabetes and pre-eclampsia risk; weight and glucose control |
| Condition | Features | Management |
|---|---|---|
| Biliary colic | Right upper quadrant or epigastric pain after meals; gallstones are 2–3 times more common in pregnancy | Analgesia, fluids, antiemetics; low-fat diet; laparoscopic cholecystectomy in the second trimester if recurrent |
| Acute cholecystitis | Fever, tenderness, raised white cells; thickened gallbladder wall on ultrasound | Antibiotics (cephalosporin ± metronidazole); laparoscopic cholecystectomy in any trimester if not settling |
| Choledocholithiasis and cholangitis | Jaundice, fever, pain; dilated bile duct | Endoscopic retrograde cholangiopancreatography (ERCP) with shielding and sphincterotomy; antibiotics |
| Imaging | Ultrasound first; magnetic resonance cholangiopancreatography (MRCP) without gadolinium if needed | Avoid CT unless the diagnosis is uncertain and life-threatening |
| Topic | Details |
|---|---|
| Causes | Gallstones (about 65–100%), hypertriglyceridaemia (triglycerides above 1,000 mg/dL, usually late pregnancy, worse with diabetes), alcohol, hyperparathyroidism, drugs, and pre-eclampsia, HELLP, or AFLP |
| Diagnosis | Epigastric pain radiating to the back with vomiting; serum lipase more than 3 times normal (amylase is less specific); ultrasound for gallstones; MRCP if needed |
| Severity | Revised Atlanta classification: mild, moderately severe, severe (persistent organ failure over 48 hours) |
| Management | IV fluids (Ringer's lactate), analgesia, antiemetics; early oral or enteral feeding; oxygen; HDU or ICU for organ failure; no routine antibiotics (only for infected necrosis or cholangitis) |
| Gallstone pancreatitis | ERCP if cholangitis or persistent obstruction; cholecystectomy in the same admission (or the second trimester or after delivery) to prevent recurrence |
| Hypertriglyceridaemia | Insulin infusion (with glucose) or plasmapheresis if triglycerides are very high; fenofibrate or omega-3 fatty acids after the acute phase; very low-fat diet |
| Pregnancy outcome | Maternal mortality is now under 1%; preterm birth about 20%; fetal loss 10–20% in severe disease; deliver for obstetric reasons, not pancreatitis alone |
Attributing a raised ALP to liver disease, or ignoring a raised ALT because 'pregnancy changes the tests'
Missing ICP in a woman with itching and normal liver tests (repeat the tests; check bile acids) — and delaying delivery when bile acids are very high
Confusing HELLP or AFLP with hepatitis, or pancreatitis with hyperemesis; delay in delivery can be fatal
Forgetting hepatitis B: not screening the mother, or missing the newborn's vaccine and HBIG within 24 hours
Missing hepatitis E in a jaundiced third-trimester woman, or stopping essential drugs (Wilson disease, immunosuppressants)



